A murine model of antibody-mediated hyperacute rejection by galactose- α(1,3)galactose antibodies in gal o/o mice

Transplantation

Volumn 66, Issue 6, 1998, Pages 754-763

  McKenzie, Ian F C ^a   Li, Yu Qin ^a   Patton, Katherine ^a   Thall, Aron D ^b   Sandrin, Mauro S ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; COMPLEMENT FIXATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

ACUTE DISEASE; AGING; ANIMALS; ANTIBODIES; ANTIGENS; DISACCHARIDES; DISEASE MODELS, ANIMAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; MALE; MICE; MICE, INBRED STRAINS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032572977     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199809270-00010     Document Type: Article

References (47)

1. Auchincloss H. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
2. Perper RJ, Najarian JS. Experimental renal heterotransplantation. I. In widely divergent species. Transplantation 1966; 4: 377.
3. Rose AG, Cooper DKC, Human PA, Reichenspurner H, Reichart B. Histopathology of hyperacute rejection of the heart: experimental and clinical observation in allografts and xenografts. J Heart Lung Transplant 1991; 10: 223.
4. Bogman MJJT, Berden JHM, Hagemann FHM, Maass CN, Keone RAP. Patterns of vascular damage in the antibody-mediated rejection of skin xenografts in the mouse. Am J Pathol 1980; 100: 727.
5. Bogman MJJT, Berden JHM, Cornelissen IMHA, Maass CN, Keone RAP. The role of complement in the induction of acute antibody-mediated vasculitis of rat skin grafts in the mouse. Am J Pathol 1982; 109: 97.
6. Williams GM, Hume DM, Hudson RP, Morris PJ, Kano K, Milgrom K. "Hyperacute" renal-homografts rejection. N Engl J Med 1968; 279: 611.
7. Good AH, Cooper DKC, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
8. Cooper DK, Good AH, Koren E, et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993; 1: 198.
9. Cooper DK, Koren E, Oriol R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141: 31.
10. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC. Antipig IgM antibodies in human serum reacts predominantly with Galα(1,3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
11. Sandrin MS, McKenzie IFC. Galα(1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev 1994; 141: 169.
12. Sandrin MS, Vaughan HA, McKenzie IFC. Identification of Galα(1,3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplant Rev 1994; 8: 134.
13. McKenzie IFC, Vaughan HA, Sandrin MS. How important are anti-Galα(1-3)Gal antibodies in pig to human xenotransplants? Xeno 1994; 2: 107.
14. Ye Y, Neethling FA, Niekrasz M, et al. Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994; 58(3): 330.
15. Cooper DKC, Koren E, Oriol R. Manipulation of the anti-αGal antibody-αGal epitope system in experimental discordant xenotransplantation. Xenotransplantation 1996; 3: 102.
16. Lin SS, Kooyman DL, Daniels LJ, et al. The role of natural anti-Galα1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transplant Immunol 1997; 5: 212.
17. Xu Y, Lorf T, Sablinski T, et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1-3Galβ1-4Glc-X immunoaffinity column. Transplantation 1998; 65: 172.
18. Larsen RD, Riverra-Marrero CA, Ernst LK, Cummings RD, Lowe JB. Frameshift and non sense mutations in a human genomic sequence homologous to a murine UDP-Gal:β-D-Gal 1,4-D-GlcNAcα1,3-galactosyl-transferase cDNA. J Biol Chem 1990; 265: 7055.
19. Joziasse DH, Shaper JH, Jabs EW, Sharper NL. Characterization of an α1,3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J Biol Chem 1991; 266: 6991.
20. Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
21. McKenzie IFC, Osman N, Cohney S, et al. Strategies to overcome the anti-Galα(1,3)Gal reaction in xenotransplantation. Transplant Proc 1996; 28: 567.
22. Ryan US. Complement inhibitory therapeutics and xenotransplantation. Nat Med 1995; 1: 967.
23. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1: 1261.
24. Sandrin MS, Cohney S, Osman N, McKenzie IFC. Overcoming the anti-Galα(1,3)Gal rejection to avoid hyperacute reaction: molecular genetic approaches. In: Cooper DKC, Kemp E, Platt JL, White DJG, eds. Xenotransplantation: the transplantation of organs and tissues between species. Berlin: Springer-Verlag, 1997: 683.
25. Sandrin MS, Osman N, McKenzie IFC. Transgenic approaches for the reduction in expression of Galα(1,3)Gal for xenotransplantation. Front Biosci 1997; 2: e1.
26. Romanella M, Aminian A, Adam WR, Pearse MJ, d'Apice AJ. Involvement of both the classical and alternate pathways of complement in an ex vivo model of xenograft rejection. Transplantation 1997; 63: 1021.
27. van Denderen BJ, Salvaris E, Romanella M, et al. Combination of decay-accelerating factor expression and α1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury. Transplantation 1997; 64: 882.
28. Tearle RG, Tange MJ, Zannettino ZL, et al. The α-1,3-galactosyltransferase knockout mouse: implications for xenotransplantation. Transplantation 1995; 61: 13.
29. Thall AD, Maly P, Lowe JB. Oocyte Galα1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem 1995; 270: 21437.
30. Baldmus CA, McKenzie IFC, Winn HJ, Russell PS. Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol 1973; 110: 1532.
31. Winn HJ, Baldmus CA, Jooste SV, Russell PS. Acute destruction by humoral antibody of rat skin grafted to mice: the role of complement and polymorphonuclear granulocytes. J Exp Med 1973; 137: 893.
32. Cohney S, McKenzie IFC, Patton K, et al. Down regulation of Galα(1,3)Gal expression in mice by the α1,2fucosyltransferase transgene. Transplantation 1997; 64: 495.
33. Vaughan HA, Oldenburg KR, Gallop MA, Atkin JD, McKenzie IFC, Sandrin MS. Recognition of an octapeptide sequence by multiple Galα(1,3)Gal-binding peptides. Xenotransplantation 1996; 3: 18.
34. McKenzie IFC, Morgan GM, Melvold RW, Kohn HI. A new H-2 mutant in BALB/c that identifies a locus associated with the D region. Immunogenetics 1977; 3: 333.
35. Corry RJ, Winn H, Russell PS. Primary vascularized allografted hearts in mice: the role of H-2D, H-2K, and non H-2 antigens in rejection. Transplantation 1973; 16: 343.
36. Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med 1984; 160: 1519.
37. Snell GD, Winn HJ, Stimpfling JH, Parker SJ. Depression by antibody of the immune response to homografts and its role in immunological enhancement. J Exp Med 1960; 112: 293.
38. Platt JL. The immunological barriers to xenotransplantation. Crit Rev Immunol 1996; 16: 331.
39. McKenzie IFC, Stocker J, Ting A, Morris PJ. Human lymphocytotoxic and hemagglutinating activity against sheep and pig cells. Lancet 1968; 2: 386.
40. Dalmasso AP, Vercellotti GM, Fischel RL, Bolman RM, Bach FH, Platt JL. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
41. Parker WR, Bruno D, Holzknecht ZE, Platt JL. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 1994; 153: 3791.
42. Platt JL, Lindman BL, Geller RL, et al. The role of natural antibodies in the activation of xenogeneic endothelial cells. Transplantation 1991; 52: 1037.
43. Magee JC, Collins BH, Harland RC, et al. Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest 1995; 96: 2404.
44. Cotterell AH, Collins BH, Parker W, Harland RC, Platt JL. The humoral response following cross-perfusion of porcine organs. Transplantation 1995; 60: 861.
45. Koike C, Kannagi R, Takamura Y, et al. Introduction of α(1,2)-fucosyltransferase and its effect on α-Gal epitopes in transgenic pig. Xenotransplantation 1996; 3: 81.
46. Sharma A, Okabe J, Birch P, et al. Reduction in the level of Gal(α1,3)Gal in transgenic mice and pigs by the expression of an α(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190.
47. Inverardi L, Clissi B, Stolzer AL, Bender JR, Sandrin MS, Pardi R. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation 1997; 63: 1318.